CVS Stock Is Tumbling. Lowered Range for Cash-Flow Guidance Unnerved Investors.
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
Updated Feb. 9, 2022 11:45 am ET / Original Feb. 9, 2022 7:19 am ET
CVS Health stock was falling after lowered cash-flow guidance overshadowed better-than-expected fourth-quarter earnings Wednesday.
The pharmacy chain reported fourth-quarter revenue of $76.6 billion, beating the FactSet consensus of $75.6 billion. Adjusted earnings per share were $1.98, which topped the FactSet consensus of $1.83.
I’m a journalist who specializes in investigative reporting and writing. I have written for the New York Times and other publications.